Cefuroxime as an empirical therapy in urinary tract infection

Details

Cefuroxime, a second-generation cephalosporin, serves as a valuable option for empirical therapy in urinary tract infections (UTIs). The management of UTIs involves swift antibiotic administration and prudent selection, considering patient response and culture results. In cases of severe symptoms or localized antibiotic resistance, empiric broad-spectrum antibiotics become essential. Cefuroxime stands out in this context, offering extensive coverage, elevated urinary concentration, and a proven track record of effectiveness and safety for UTI treatment. This antibiotic is a go-to option for empirical therapy in UTI management.

ALSO VIEW